Alash'le Abimiku
#62,944
Most Influential Person Now
Epidemiologist
Alash'le Abimiku's AcademicInfluence.com Rankings
Alash'le Abimikumedical Degrees
Medical
#2514
World Rank
#2941
Historical Rank
Public Health
#668
World Rank
#690
Historical Rank
Epidemiology
#812
World Rank
#847
Historical Rank
Download Badge
Medical
Alash'le Abimiku's Degrees
- Bachelors Medicine University of Jos
- Masters Public Health University of California, Berkeley
- PhD Epidemiology University of California, Berkeley
Why Is Alash'le Abimiku Influential?
(Suggest an Edit or Addition)According to Wikipedia, Alash'le Grace Abimiku is a Nigerian executive director of the International Research Centre of Excellence at the Institute of Human Virology Nigeria and a professor of virology at the University of Maryland School of Medicine who takes interest in the prevention and treatment of HIV.
Alash'le Abimiku's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Laboratory Diagnosis of Tuberculosis in Resource-Poor Countries: Challenges and Opportunities (2011) (468)
- Enabling the genomic revolution in Africa (2014) (327)
- A Comprehensive Panel of Near-Full-Length Clones and Reference Sequences for Non-Subtype B Isolates of Human Immunodeficiency Virus Type 1 (1998) (305)
- Viremia control following antiretroviral treatment and therapeutic immunization during primary SIV251 infection of macaques (2000) (213)
- Patient Retention and Adherence to Antiretrovirals in a Large Antiretroviral Therapy Program in Nigeria: A Longitudinal Analysis for Risk Factors (2010) (155)
- Update on HIV-1 diversity in Africa: a decade in review. (2012) (137)
- Prevalence of Non-Tuberculous Mycobacterial Infections among Tuberculosis Suspects in Nigeria (2013) (89)
- H3Africa: current perspectives (2018) (85)
- Immuno-virologic outcomes and immuno-virologic discordance among adults alive and on anti-retroviral therapy at 12 months in Nigeria (2013) (76)
- Highly attenuated HIV type 2 recombinant poxviruses, but not HIV-2 recombinant Salmonella vaccines, induce long-lasting protection in rhesus macaques. (1995) (76)
- Associations between Cognition, Gender and Monocyte Activation among HIV Infected Individuals in Nigeria (2016) (74)
- HIV-1 recombinant poxvirus vaccine induces cross-protection against HIV-2 challenge in rhesus macaques (1995) (74)
- Comprehensive Reference Ranges for Hematology and Clinical Chemistry Laboratory Parameters Derived from Normal Nigerian Adults (2014) (72)
- Reference Values of CD4 T Lymphocytes in Human Immunodeficiency Virus-Negative Adult Nigerians (2005) (67)
- Building laboratory infrastructure to support scale-up of HIV/AIDS treatment, care, and prevention: in-country experience. (2009) (64)
- Subgroup G HIV type 1 isolates from Nigeria. (1994) (56)
- Social determinants of mixed feeding behavior among HIV-infected mothers in Jos, Nigeria (2009) (52)
- TLR10 Senses HIV-1 Proteins and Significantly Enhances HIV-1 Infection (2019) (47)
- Early antiretroviral therapy initiation: access and equity of viral load testing for HIV treatment monitoring. (2017) (47)
- Clinical features and preliminary studies of virological correlates of neurocognitive impairment among HIV-infected individuals in Nigeria (2012) (45)
- Cost-effectiveness of new WHO recommendations for prevention of mother-to-child transmission of HIV in a resource-limited setting (2011) (44)
- Update on HIV-1 acquired and transmitted drug resistance in Africa. (2015) (41)
- Timing and determinants of mother‐to‐child transmission of HIV in Nigeria (2009) (41)
- Drug susceptibility testing and mortality in patients treated for tuberculosis in high-burden countries (2018) (37)
- Cross-Reactivity of Two SARS-CoV-2 Serological Assays in a Setting Where Malaria Is Endemic (2021) (33)
- Mycobacterial Etiology of Pulmonary Tuberculosis and Association with HIV Infection and Multidrug Resistance in Northern Nigeria (2013) (32)
- Doing No Harm? Adverse Events in a Nation-Wide Cohort of Patients with Multidrug-Resistant Tuberculosis in Nigeria (2015) (32)
- Neurocognitive impairment associated with predominantly early stage HIV infection in Abuja, Nigeria (2014) (32)
- Compromised Growth Among HIV-exposed Uninfected Compared With Unexposed Children in Nigeria (2019) (29)
- Tenofovir-based regimens associated with less drug resistance in HIV-1-infected Nigerians failing first-line antiretroviral therapy (2013) (29)
- Socio-Demographic and Adherence Factors Associated with Viral Load Suppression in HIV-Infected Adults Initiating Therapy in Northern Nigeria: A Randomized Controlled Trial of a Peer Support Intervention. (2015) (24)
- Addressing the under-reporting of adverse drug reactions in public health programs controlling HIV/AIDS, Tuberculosis and Malaria: A prospective cohort study (2018) (24)
- Characterization of acute HIV-1 infection in high-risk Nigerian populations. (2012) (23)
- HIV infection awareness and willingness to participate in future HIV vaccine trials across different risk groups in Abuja, Nigeria (2010) (21)
- Sustainable clinical laboratory capacity for health in Africa. (2017) (21)
- Laboratory medicine in Africa since 2008: then, now, and the future. (2018) (21)
- African AIDS Vaccine Programme for a Coordinated and Collaborative Vaccine Development Effort on the Continent (2008) (18)
- Humoral and cellular immune responses in rhesus macaques infected with human immunodeficiency virus type 2. (1995) (18)
- Cross-protection in NYVAC–HIV-1-immunized/HIV-2-challenged but not in NYVAC–HIV-2-immunized/SHIV-challenged rhesus macaques (2000) (16)
- Optimising Mycobacterium tuberculosis detection in resource limited settings (2014) (16)
- Peripheral blood lymphocyte HIV DNA levels correlate with HIV associated neurocognitive disorders in Nigeria (2017) (15)
- Demography and the dual epidemics of tuberculosis and HIV: Analysis of cross-sectional data from Sub-Saharan Africa (2018) (15)
- Altered cord blood gammadelta T cell repertoire in Nigeria: possible impacts of environmental factors on neonatal immunity. (2008) (15)
- Soluble Toll-like receptor 2 is significantly elevated in HIV-1 infected breast milk and inhibits HIV-1 induced cellular activation, inflammation and infection (2014) (14)
- Breastfeeding mitigates the effects of maternal HIV on infant infectious morbidity in the Option B+ era (2018) (14)
- Bacille Calmette-Guérin Vaccine Strain Modulates the Ontogeny of Both Mycobacterial-Specific and Heterologous T Cell Immunity to Vaccination in Infants (2019) (13)
- Development, Evaluation, and Implementation of a Pan-African Cancer Research Network: Men of African Descent and Carcinoma of the Prostate (2018) (12)
- Cost-effectiveness of point-of-care digital chest-x-ray in HIV patients with pulmonary mycobacterial infections in Nigeria (2014) (11)
- Missed opportunities for early infant diagnosis of HIV in rural North-Central Nigeria: A cascade analysis from the INSPIRE MoMent study (2019) (11)
- Adherence to Anti-Retroviral Therapy in North Central Nigeria. (2015) (10)
- Performance of Genotype MTBDRplus in the Detection of Resistance to Rifampicin and Isoniazid Among Clinical Mycobacteria Isolates in Ilorin, Nigeria. (2015) (9)
- Experiences in establishing a PEPFAR-supported laboratory quality system in Nigeria. (2010) (9)
- Plasma HIV RNA level is associated with neurocognitive function among HIV-1-infected patients in Nigeria (2018) (9)
- Cost of three models of care for drug-resistant tuberculosis patients in Nigeria (2019) (9)
- Expression profiling of human milk derived exosomal microRNAs and their targets in HIV-1 infected mothers (2020) (9)
- Preparing for HIV Vaccine Trials in Nigeria: Building the Capacity of the Community and National Coordinating, Regulatory and Ethical Bodies (2013) (9)
- Risk factors associated with low CD4+ lymphocyte count among HIV‐positive pregnant women in Nigeria (2009) (8)
- Mortality from drug-resistant tuberculosis in high-burden countries comparing routine drug susceptibility testing with whole-genome sequencing: a multicentre cohort study (2021) (8)
- Prevalence of hypertension among patients aged 50 and older living with human immunodeficiency virus (2019) (8)
- Assuring the quality of diagnostic testing: The future is now (2016) (8)
- Accessing Biospecimens from the H3Africa Consortium (2017) (7)
- HIV subtype and drug resistance patterns among drug naïve persons in Jos, Nigeria (2007) (7)
- Genes for Life: Biobanking for Genetic Research in Africa (2017) (7)
- Active tracking of rejected dried blood samples in a large program in Nigeria. (2016) (7)
- Elevated Plasma Levels of sCD14 and MCP-1 are associated with HIV Associated Neurocognitive Disorders among Antiretroviral Naïve Individuals in Nigeria. (2020) (7)
- Brief Report: Body Mass Index and Cognitive Function Among HIV-1–Infected Individuals in China, India, and Nigeria (2019) (7)
- Laboratory Innovation Towards Quality Program Sustainability (2016) (6)
- Analysis of Reported Cases of Lassa Fever in Plateau State and the Need for Strategic Action Plan (2016) (6)
- Characterisation of HIV-1 Molecular Epidemiology in Nigeria: Origin, Diversity, Demography and Geographic Spread (2020) (6)
- Current Trends in the detection of Acute HIV Infection among Blood Donors:Reliability of Pooled Nucleic Acid Amplification Technology and the Need forPopulation Specific Algorithms: A Systematic Review (2015) (5)
- The role of connected diagnostics in strengthening regional, national and continental African disease surveillance (2018) (5)
- Cross-reactivity of two SARS-CoV-2 serological assays in a malaria-endemic setting (2021) (5)
- Cost comparison of nine-month treatment regimens with 20-month standardized care for the treatment of rifampicin-resistant/multi-drug resistant tuberculosis in Nigeria (2020) (5)
- 8th IAS Conference on HIV Pathogenesis, Treatment & Prevention 19–22 July 2015, Vancouver, Canada (2015) (5)
- TLR 10 Senses HIV-1 Proteins and Significantly Enhances HIV-1 Infection (2019) (5)
- Long-Term Outcome of Second-Line Antiretroviral Therapy in Resource-Limited Settings (2014) (5)
- Selecting a Laboratory Information Management System for Biorepositories in Low- and Middle-Income Countries: The H3Africa Experience and Lessons Learned (2017) (5)
- High frequency of HIV-1 dual infections in Cameroon, West Central Africa. (2011) (5)
- Public Health Aspects of HIV/AIDS – Nigeria and West Africa (2008) (5)
- Performance and trend for quality of service in a large HIV/AIDS treatment program in Nigeria (2019) (5)
- Characterisation of HIV-1 Molecular Epidemiology in Nigeria: Origin, Diversity, Demography and Geographic Spread (2018) (4)
- Oral abstracts of the 21st International AIDS Conference 18–22 July 2016, Durban, South Africa (2016) (4)
- Performance of HIV rapid testing algorithm in Nigeria: Findings from a household-based Nigeria HIV/AIDS Indicator and Impact Survey (NAIIS) (2022) (4)
- Lessons From Rapid Field Implementation of an HIV Population-Based Survey in Nigeria, 2018 (2021) (4)
- Predictors of first-line antiretroviral therapy failure among adults and adolescents living with HIV/AIDS in a large prevention and treatment program in Nigeria (2020) (4)
- Erratum to: Barriers to and Facilitators of Adherence to Exclusive Breastfeeding Practices Among HIV Infected and Non-Infected Women in Jos, Nigeria (2017) (4)
- Community stakeholder engagement during a vaccine demonstration project in Nigeria: lessons on implementation of the good participatory practice guidelines (2019) (4)
- A Decade of Monitoring HIV Epidemics in Nigeria: Positioning for Post-2015 Agenda (2017) (4)
- HIV Coinfection Is Associated with Low-Fitness rpoB Variants in Rifampicin-Resistant Mycobacterium tuberculosis (2020) (3)
- Validation of xMAP SARS-CoV-2 Multi-Antigen IgG assay in Nigeria (2022) (3)
- Development of a prospective cohort of HIV Exposed Sero-Negative (HESN) individuals in Jos Nigeria (2016) (3)
- Prevalence and risk factors for obesity among elderly patients living with HIV/AIDS in a low-resource setting (2021) (3)
- Blueprint for building a biorepository in a resource-limited setting that follows international best practices (2019) (3)
- Cognitive Function Among Antiretroviral Treatment–Naive Individuals Infected With Human Immunodeficiency Virus Type 1 Subtype G Versus CRF02_AG in Nigeria (2018) (3)
- Appraisal of repeat intrapartum human immunodeficiency virus screening in a prevention of mother-to-child transmission program in Nigeria (2013) (3)
- Can oral fluid testing be used to replace blood-based HIV rapid testing to scale up access to diagnosis and treatment in Cameroon? (2011) (3)
- Diagnostic system strengthening for drug resistant tuberculosis in Nigeria: impact and challenges (2017) (3)
- Correction: Comprehensive Reference Ranges for Hematology and Clinical Chemistry Laboratory Parameters Derived from Normal Nigerian Adults (2014) (2)
- Preliminary Report on HIV-1 Vaccine Preparedness in Nigeria: Advantages of Recruiting University Students (2010) (2)
- Afri-Can Forum 2 (2016) (2)
- Seroprevalence of SARS-CoV-2 in four states of Nigeria in October 2020: A population-based household survey (2022) (2)
- Afri-Can Forum 2 (2016) (2)
- Afri-Can Forum 2 (2016) (2)
- Afri-Can Forum 2 (2016) (2)
- PG-1 Compromised growth among HIV exposed compared to unexposed children in Nigeria (2019) (2)
- H3Africa partnerships to empower clinical research sites to generate high-quality biological samples (2020) (2)
- Providing antiretroviral therapy outside the hospital in a low-resource setting: a pilot study (2018) (1)
- Long-term outcome of second-line antiretroviral therapy in resource-limited settings. (2014) (1)
- 227 Opportunity for Scale -Up; Mobile X-ray Technology- Strengthening TB Diagnosis in HIV+ve Patients; ACTION Experience in Zaria, rural Northern Nigeria (2009) (1)
- A23 Identification of HIV drug resistance mutation patterns using illumina MiSeq next generation sequencing in patients failing second-line boosted protease inhibitor therapy in Nigeria (2017) (1)
- 245 Outcome of early infant diagnosis in exposed infants in Northern Nigeria (2009) (1)
- HPTN 069/ACTG A5305: phase II study of maraviroc-containing regimens for HIV PrEP in US women; Postive impact of a randomized controlled trial of the Uthando Lwethu ("Our Love") intervention on rates of couples HIV testing in rural South Africa (2016) (1)
- Operation Save the World from Adverse Drug Reactions: findings from a drug safety surveillance programme in Nigeria (2019) (1)
- Improved Performance of COBAS AmpliPrep/COBAS TaqMan Version 2.0 Assay Over Amplicor Monitor Version 1.5 in the Quantification of HIV-1 RNA Viral Load in Abuja, Nigeria. (2015) (1)
- Considerations for quality assurance of multiplex malaria antigen detection assays with large sample sets (2021) (1)
- Closing the NIH Fogarty Center threatens US and global health (2017) (1)
- A101 Pattern of mycobacterial infections and their associations with HIV among laboratory confirmed cases of pulmonary tuberculosis in Nigeria (2013) (1)
- P-A3 Drug Resistance after Second Line Failure can be Managed Using WHO Recommended Regimens in Nigeria (2014) (1)
- Plasma HIV RNA level is associated with neurocognitive function among HIV-1-infected patients in Nigeria (2018) (1)
- AF2 Pattern of Drug Resistant Mutations Among Nigerian Patients on PEPFAR NRTINNRTI Regimens (2012) (1)
- Edinburgh Research Explorer A comprehensive panel of near-full-length clones and reference sequences for non-subtype B isolates of human immunodeficiency virus type 1 (1998) (0)
- Factors associated with receipt of a timely infant birth dose of hepatitis B vaccine at a tertiary hospital in North-Central Nigeria (2022) (0)
- Molecular Detection and Characterisation of Lassa Fever Virus among Patients Attending Tertiary Hospitals in Jos, Central Nigeria (2018) (0)
- CAHR 2014 poster (2014) (0)
- P-E14 An observational cohort of post-natal HIV transmission among women on HAART who breastfeed their infants in Nigeria: Findings from the INFANT study (2017) (0)
- “MicroRNA expression profiling of human milk derived exosomes identifies miR-630 and miR-378g as biomarkers in HIV-1 infected women” (2020) (0)
- Implementation of data triangulation and dashboard development for COVID-19 vaccine adverse event following immunisation (AEFI) data in Nigeria (2023) (0)
- Baseline Clinical Profile of a “Normal Popu-lation” of HIV Exposed Sero-Negative (HESN) Partners May Impact HIV Biomedical Prevention Studies Negatively (2015) (0)
- AIDS Vaccine 2013_ Poster presentation (2013) (0)
- Tuberculosis Infection Control Practice among Antiretroviral (ART) Clinics in North Central Nigeria (2022) (0)
- Back-to-Africa introductions of Mycobacterium tuberculosis as the main cause of tuberculosis in Dar es Salaam, Tanzania (2022) (0)
- Limited emergence of resistance to Integrase strand transfer inhibitors (INSTIs) in HIV-experienced patients failing dolutegravir-based antiretroviral therapy: Cross-sectional analysis from a Northeast Nigerian cohort (2022) (0)
- Evaluation of the Nigeria national HIV rapid testing algorithm (2022) (0)
- A106 Neurocognitive Impairment among Treatment-Naïve HIV-Infected Individuals in Nigeria (2013) (0)
- 196 Newly Identified Circulating Recombinant Form Common in Nigeria (2011) (0)
- Evaluation of accuracy and performance of self-reported HIV and antiretroviral therapy status in the Nigeria AIDS Indicator and Impact Survey (2018) (2022) (0)
- A104 Improving laboratory capacity in Africa through step-wise accreditation program (2013) (0)
- Factors associated with viral suppression among adults living with HIV on antiretroviral therapy in Nigeria: Analysis of a population-based survey, 2018. (2023) (0)
- BMC ID Chuka Anude (2014) (0)
- 246 Interface of Public Health Implementation and Research - Challenges and Prospects - IHVN/ Action Project Experience (2009) (0)
- P-D15 Peripheral blood lymphocyte HIV DNA levels correlate with HIV associated neurocognitive disorders (2016) (0)
- P-E1 Immunologic Criteria are Poor Predictors of Virologic Out-comes: Implications for HIV Monitoring in a Large Treatment Program in Nigeria (2017) (0)
- Neurocognitive Impairment Related to HIV Infection in Nigeria (P01.259) (2012) (0)
- HIV Viral Dynamics of Lopinavir/Ritonavir Monotherapy as Second-Line Treatment: A Prospective, Single-Arm Trial (2019) (0)
- Mortality of Drug-resistant Tuberculosis in High-burden Countries: Comparison of Routine Drug Susceptibility Testing with Whole-genome Sequencing (2020) (0)
- AF6 The HACART Study: Predictors of Immuno-Virologic Outcomes and Immuno-Virologic Discordance Among Adults on HIV Antiretroviral Therapy in Nigeria (2012) (0)
- Evaluation of Genxpert Real Time PCR POC in the Diagnosis of Multidrug Resistant TB Among Patients Attending NTBLTC Saye-Zaria Nigeria (2018) (0)
- Strategies for Good Retention Rates in HIV Exposed Sero-Negatives (HESN) Individuals: Important Consideration for HIV Biomedical Prevention Trials in Nigeria (2018) (0)
- Corrigendum: Assuring the quality of diagnostic testing: the future is now (2017) (0)
- 235 Quality ART Scale Up Through Regionalization of Laboratory Services In Nigeria (2009) (0)
- Correction: Cost comparison of nine-month treatment regimens with 20-month standardized care for the treatment of rifampicin-resistant/multi-drug resistant tuberculosis in Nigeria (2021) (0)
- Clinical features and preliminary studies of virological correlates of neurocognitive impairment among HIV-infected individuals in Nigeria (2012) (0)
- A3 Molecular epidemiology of HIV-1 in Nigeria (2019) (0)
- Erratum to: Clinical features and preliminary studies of virological correlates of neurocognitive impairment among HIV-infected individuals in Nigeria (2012) (0)
- P-D6 Elevated plasma HIV RNA level is associated with impaired neurocognitive function among HIV-1 infected patients in Nigeria (2018) (0)
- Implementing an intensified mentorship approach towards accelerated medical laboratory accreditation in 10 counties in Kenya (2022) (0)
- Monkeypox (Mpox) requires continued surveillance, vaccines, therapeutics and mitigating strategies (2023) (0)
- Challenges Faced with Implementation of Viral Load Services in Achieving Epidemic Control in Nigeria. (2018) (0)
- CUGH 2019 / ORAL ABSTRACT PRESENTATIONS CS02.001 Free Facilities or False Promises: A Mixed Method Study to Understand the Effects of Accredited Social Health Activists’ Home Visits on Maternal and Newborn Health Equity in Uttar Pradesh, India (2019) (0)
- Immunity in Nigerian women and the effects of pregnancy and infectious disease exposure on fetal immunity (2006) (0)
- Affordable Method For Quality DNA For Genomic Research In Low To Middle-Income Country Research Settings. (2020) (0)
- Neurocognitive impairment associated with predominantly early stage HIV infection in Abuja, Nigeria (2014) (0)
- A-104 Gender and Neurocognitive Impairment among HIV Infected Individuals in Nigeria (2014) (0)
- Erratum to: Clinical features and preliminary studies of virological correlates of neurocognitive impairment among HIV-infected individuals in Nigeria (2012) (0)
- Complexities of a Continent (2008) (0)
- Prevalence of HIV drug resistance in Nigeria: results from a cross-sectional, population-based survey of Nigerian adults with unsuppressed viral load (2022) (0)
- Peripheral blood lymphocyte HIV DNA levels correlate with HIV associated neurocognitive disorders in Nigeria (2017) (0)
- HIV Associated Neurocognitive Disorders (HAND) in Nigeria: Clinical Rating versus Global Deficit Score Methods (P5.043) (2015) (0)
- Implementing quality assurance for laboratory-based and point-of-care HIV testing in Nigeria (2016) (0)
This paper list is powered by the following services:
Other Resources About Alash'le Abimiku
What Schools Are Affiliated With Alash'le Abimiku?
Alash'le Abimiku is affiliated with the following schools:
